Finally, CD138 in synergy with HPSE has been shown to promote MM bone disease by activating the HGF-Met-IL-11-RANKL signaling axis, resulting in inhibition of bone formation and promotion of bone resorption (134). This evidence concerns the gene MET and Miyoshi myopathy.